NDC 0009-0268 - Heparin Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0009-0268
- Package NDCs from labels
- 0009-0268-01, 0009-0268-12, 0009-0268-02
- Effective date
- 2006-04-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Heparin Sodium Injection, USP | 2006-04-13 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0009-0268-01 | Heparin Sodium | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 1 | |
| 0009-0268-02 | Heparin Sodium | 30 mL in 1 VIAL | INJECTION, SOLUTION | 30 | 1 | |
| 0009-0268-12 | Heparin Sodium | 25 in 1 PACKAGE | INJECTION, SOLUTION | 25 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Heparin Sodium | ACTIVE INGREDIENT | ZZ45AB24CA | HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION | 1 | |
| Heparin | ACTIVE MOIETY | T2410KM04A | HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION | 1 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | 239b4816-6a55-451b-bf40-e611be07d12f | 2026-08-10 | Warnings, Adverse reactions | 1361226 |
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | e0cc5f44-9a67-4274-a48a-d6118e96d391 | 2026-06-25 | Warnings, Adverse reactions | 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Cardinal Health 107, LLC | f67eea4e-80ff-48da-8b04-8addc5cd31d1 | 2026-05-12 | Warnings, Adverse reactions | 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | 2a173253-dfdc-4d9d-8dee-b9c13e6fa9f5 | 2026-04-30 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Plano Pharmaceuticals Inc. | 4deaa9ac-91aa-d96b-e063-6294a90a47bd | 2026-03-25 | Warnings, Adverse reactions | 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | 6c181d7e-aed2-4975-30ac-d39a94cca7ec | 2026-03-24 | Warnings, Adverse reactions | 1361226 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Medical Purchasing Solutions, LLC | 4c118b39-cb4e-31a9-e063-6394a90a41b0 | 2026-03-02 | Warnings, Adverse reactions | 1361226 |
| Heparin Sodium | HEPARIN SODIUM | Medical Purchasing Solutions, LLC | 463e0624-b8c3-386b-e063-6294a90afd28 | 2025-12-18 | Warnings, Adverse reactions | 1361226 |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | d55b4a63-0c04-4874-b74f-9e9b9e8b008c | 2025-11-28 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | ed937dd2-8fab-4875-a1e8-627b71ccb7fb | 2025-11-27 | Warnings, Adverse reactions | 1361226 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Sagent Pharmaceticals | ef309d83-7262-4874-8580-f4ca254f963a | 2025-11-18 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Sagent Pharmaceuticals | 8ebe4b4d-cb28-47e8-9598-6105d250b3d2 | 2025-11-18 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Henry Schein, Inc. | 3a998729-c912-4e21-8e49-d1e72ba6fe9e | 2025-10-31 | Warnings, Adverse reactions | 1361226 |
| Heparin Sodium | HEPARIN SODIUM | Pfizer Laboratories Div Pfizer Inc | 56dc3074-f1c5-45a3-b923-f1d14858e06d | 2025-10-03 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Meitheal Pharmaceuticals Inc. | 02fb700d-a28c-4d45-b78d-382dc0d5986c | 2025-09-26 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Medical Purchasing Solutions, LLC | 3edf9198-b88d-7808-e063-6394a90ae89c | 2025-09-15 | Warnings, Adverse reactions | 1361226 |
| Heparin Sodium | HEPARIN SODIUM | Medical Purchasing Solutions, LLC. | 3ea2bd53-ed13-a516-e063-6394a90a5dd9 | 2025-09-12 | Warnings, Adverse reactions | 1361226 |
| Heparin Sodium | HEPARIN SODIUM | Hikma Pharmaceuticals USA Inc. | 7014808d-cec9-4b2c-8eb5-940493e356ab | 2025-08-13 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
| Heparin Sodium | HEPARIN SODIUM | NorthStar RxLLC | c4fa6d34-e76b-4c3c-b74d-21ce41432a04 | 2025-05-29 | Warnings, Adverse reactions | 1361226 1361615 |
| Heparin Sodium | HEPARIN SODIUM | Mylan Institutional LLC | 88114716-5759-4bc9-8a85-d28da12962cc | 2025-04-15 | Warnings, Adverse reactions | 1361226 1362831 1361615 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.